1 1

Molfinity

Etrolizumab - CAS 1044758-60-2

Etrolizumab - CAS 1044758-60-2

MF-0099300-01

$311.50 USD
$311.50 USD
Sale Sold out
Taxes included.
Size
View full details

Product Details

  • Bioactivity

    Etrolizumab (rhuMAb Beta7) is a humanized intestinal-selective anti-β7 integrin monoclonal antibody that selectively blocks the transport and retention of lymphocytes in the intestinal tract for the study of inflammatory bowel disease (IBD) .

  • Target

    Integrin

  • Related Pathways

    Cytoskeletal Signaling

  • CAS Number

    1044696

  • Purity

    0.989

  • Storage Temperature

    -20°C

  • Shipping Conditions

    Ice Packs

  • Category

    Inhibitory Antibodies